Mastering Complexity of Multi-Specific Biologics: Tailored Solutions and Advanced Bioassay Development

Discover WuXi Biologic's unique approach to mechanism of action analysis and risk assessment.

Register Free: https://www.biopharminternational.com/bp_w/advanced-bioassay-development

Event Overview:

This presentation delves into the critical challenges of bioassay development for multi-specific biologics, addressing key complexities. Experts from WuXi Biologics’ Bioassay Centre of Excellence (BCOE) showcase innovative strategies through real-world case studies, including the bioassay development of bispecific T-cell engagers and multi-specific probodies. Leveraging expertise in bioactivity method development, BCOE provides end-to-end CMC service and flexible standalone services.

Key Learning Objectives:

• The challenges and complexity of multi-specific biologics
• WuXi Biologics’ approach and solution: mechanism of action analysis and risk assessment
• Case study: bispecific T-cell engager with functional analysis
• Case study: multi-specific probody

Speaker:

Dr Qing Cai
WuXi Biologics

Dr. Qing Cai graduated with a PhD in Biochemistry and Molecular Biology from University College London (UCL), joining WuXi Biologics’ Analytical Sciences department in 2017. As a subject matter expert and sponsor, Dr. Cai has led hundreds of bioassay development and testing products. She currently serves as Director of the BCOE, dedicated to designing phase-appropriate bioassay strategies for global biopharmaceutical programs and delivering high-quality solutions for potency assay development, method research, and standalone testing services.

Register Free: https://www.biopharminternational.com/bp_w/advanced-bioassay-development